小金片治疗乳腺增生合并子宫肌瘤的疗效观察  

The curative effect of Xiao Jin tablet on hyperplasia of mammary glands and hysteromyoma

作　　者：倪艳梅[1] 

机构地区：[1]航天中心医院,北京100049

出　　处：《中国处方药》2017年第11期82-84,共3页Journal of China Prescription Drug

摘　　要：目的观察小金片治疗乳腺增生合并子宫肌瘤的临床疗效。方法选取自2013年1月~2015年1月收治的120例乳腺增生合并子宫肌瘤的患者,按照随机双盲、安慰剂对照临床试验方法,将患者分为治疗组和对照组,每组60例。对照组患者服用安慰剂做空白对照,治疗组患者口服小金片治疗。观察两组患者治疗前后的乳房肿块大小变化情况、子宫肌瘤大小变化情况、总有效率,并作记录分析。结果治疗后,对照组患者的乳房肿块和子宫肌瘤的平均大小明显大于治疗组患者,差异均具统计学意义(P<0.05)。对照组总有效率为30.00%,而治疗组总有效率为76.67%,两者差异均有统计学意义(P<0.05)。结论小金片在治疗子宫肌瘤合并乳腺增生时有较好的临床疗效。Objective To observe the curative effect of XiaoJin tablet on byperplasia of mammary glands and hysteromyoma. Methods From January 2013 to January 2015, 120 cases of hyperplasia of mammary glands of patients with uterine fibroids, in accordance with the principle of random, double blind and placebo-controlled distribution would be divided into a control group and treatment group, 60 cases in each group. Patients in the control group received a placebo as blank control, oral treatment group patients took XiaoJin tablet. Observed all patients＇ breast size change, myoma of uterus size changes, overall efficiency, and log analysis before and after treatment. Results XiaoJin tablet in the treatment of hyperplasia of mammary glands got a good the curative effect. After treatment, Patients in the control group, average size of the breast masses and average size of uterine myoma significantly were greater than those of the treatment group, there were significant in the two （P 〈 0.05 ）. Control group＇ s total effective rate was 80%, and the treatment group was 76.67%. There were significant differences between the two （P 〈 0.05） . Conclusion XiaoJin tablet in the treatment of uterine myoma combined hyperplasia of mammary glands can be applied in clinical practice with a better clinical efficacy.

关 键 词：小金片 乳腺增生合并子宫肌瘤 临床疗效 

分 类 号：R269[医药卫生—中西医结合]